F. Gentile

Late sodium current inhibitors to treat exercise‐induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium

R. Matucci, A. Mugelli, I. Olivotto, 2018, British journal of pharmacology.

Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy

A. Mugelli, I. Olivotto, C. Poggesi, 2017, Circulation. Heart failure.

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations

I. Olivotto, C. Poggesi, J. Tardiff, 2022, Frontiers in Physiology.

Life-Long Treatment with Late Sodium Current Blocker Reduces Myocardial Dysfunction and Remodeling in a Mouse Model of Hypertrophic Cardiomyopathy

J. Tardif, A. Mugelli, C. Poggesi, 2015 .

Clinical and Neurophysiological Follow-Up of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Subcutaneous Immunoglobulins: A Real-Life Single Center Study

M. Gangitano, F. Brighina, V. Di Stefano, 2022, Brain sciences.

Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models

A. Mugelli, I. Olivotto, C. Poggesi, 2017, Journal of the American Heart Association.

The Selective Antagonism of P2X7 and P2Y1 Receptors Prevents Synaptic Failure and Affects Cell Proliferation Induced by Oxygen and Glucose Deprivation in Rat Dentate Gyrus

F. Pedata, M. Giovannini, T. Mello, 2014, PloS one.

Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy

A. Mugelli, I. Olivotto, C. Poggesi, 2017, Circulation. Heart failure.